Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia.

Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y.

Pediatr Cardiol. 2017 Oct;38(7):1450-1455. doi: 10.1007/s00246-017-1683-9. Epub 2017 Jul 28.

2.

Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.

Saul JP, Schaffer MS, Karpawich PP, Erickson CC, Epstein MR, Melikian AP, Shi J, Karara AH, Cai B, Hinderling PH.

J Clin Pharmacol. 2001 Jan;41(1):35-43.

PMID:
11144992
3.

Developing a safe intravenous sotalol dosing regimen.

Somberg JC, Preston RA, Ranade V, Molnar J.

Am J Ther. 2010 Jul-Aug;17(4):365-72. doi: 10.1097/MJT.0b013e3181ea3184.

PMID:
20562595
4.

High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias.

Knudson JD, Cannon BC, Kim JJ, Moffett BS.

Pediatr Cardiol. 2011 Oct;32(7):896-903. doi: 10.1007/s00246-011-0010-0. Epub 2011 May 8.

PMID:
21553267
5.
6.

Efficacy and proarrhythmia of oral sotalol in pediatric patients.

Pfammatter JP, Paul T, Lehmann C, Kallfelz HC.

J Am Coll Cardiol. 1995 Oct;26(4):1002-7.

7.

Sotalol in treatment of pediatric cardiac arrhythmias.

Celiker A, Ayabakan C, Ozer S, Ozme S.

Pediatr Int. 2001 Dec;43(6):624-30.

PMID:
11737739
8.

Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.

Saul JP, Ross B, Schaffer MS, Beerman L, Melikian AP, Shi J, Williams J, Barbey JT, Jin J, Hinderling PH; Pediatric Sotalol Investigators.

Clin Pharmacol Ther. 2001 Mar;69(3):145-57.

9.

Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.

Raman V, Krishnamurthy S, Harichandrakumar KT.

Pediatr Nephrol. 2016 Apr;31(4):595-604. doi: 10.1007/s00467-015-3285-1. Epub 2016 Jan 12.

PMID:
26759000
10.

Vancomycin dosing in children and young adults: back to the drawing board.

Camaione L, Elliott K, Mitchell-Van Steele A, Lomaestro B, Pai MP.

Pharmacotherapy. 2013 Dec;33(12):1278-87. doi: 10.1002/phar.1345. Epub 2013 Sep 9.

PMID:
24019205
11.

Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.

Price JF, Kertesz NJ, Snyder CS, Friedman RA, Fenrich AL.

J Am Coll Cardiol. 2002 Feb 6;39(3):517-20.

12.

Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol.

Rao SO, Boramanand NK, Burton DA, Perry JC.

Int J Cardiol. 2009 Aug 21;136(3):253-7. doi: 10.1016/j.ijcard.2008.04.060. Epub 2008 Jul 23.

PMID:
18653253
13.

Low-dose sotalol in pediatric arrhythmia therapy.

Rokicki W, Dukalska M.

Pediatr Cardiol. 1999 Mar-Apr;20(2):172-3. No abstract available.

PMID:
9986903
14.

Efficacy and safety of sotalol for refractory tachyarrhythmias in congenital heart disease.

Miyazaki A, Ohuchi H, Kurosaki K, Kamakura S, Yagihara T, Yamada O.

Circ J. 2008 Dec;72(12):1998-2003. Epub 2008 Oct 17.

15.

A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.

Weidle PJ, Abrams EJ, Gvetadze R, Rivadeneira E, Kline MW.

Pediatr Infect Dis J. 2006 Jan;25(1):59-64.

PMID:
16395105
16.

QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol.

Somberg JC, Preston RA, Ranade V, Molnar J.

Cardiology. 2010;116(3):219-25. doi: 10.1159/000316050. Epub 2010 Aug 7.

PMID:
20693799
17.

Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.

Kochiadakis GE, Igoumenidis NE, Marketou ME, Solomou MC, Kanoupakis EM, Vardas PE.

Am J Cardiol. 1998 Apr 15;81(8):995-8.

PMID:
9576159
18.

Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement.

Finks SW, Rogers KC, Manguso AH.

Int J Pharm Pract. 2011 Aug;19(4):281-6. doi: 10.1111/j.2042-7174.2011.00094.x. Epub 2011 Mar 15.

PMID:
21733016
19.

Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.

Li X, Zhang Y, Liu H, Jiang H, Ge H, Zhang Y.

Am J Cardiol. 2017 May 1;119(9):1366-1370. doi: 10.1016/j.amjcard.2017.01.034. Epub 2017 Feb 10.

20.

Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia.

Shi J, Ludden TM, Melikian AP, Gastonguay MR, Hinderling PH.

J Pharmacokinet Pharmacodyn. 2001 Dec;28(6):555-75.

PMID:
11999292

Supplemental Content

Support Center